ArticleMolecules (Basel, Switzerland)2017
Kinetics and Molecular Docking Studies of 6-Formyl Umbelliferone Isolated from Angelica decursiva as an Inhibitor of Cholinesterase and BACE1.
Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 33 citations in OpenAlex.
- Umbelliferone and Its Synthetic Derivatives as Suitable Molecules for the Development of Agents with Biological Activities: A Review of Their Pharmacological and Therapeutic Potential.Pharmaceuticals (Basel, Switzerland) · 2023Review
- Umbelliferon: a review of its pharmacology, toxicity and pharmacokinetics.Inflammopharmacology · 2023Review
- Glucosinolates and Biotic Stress Tolerance in Brassicaceae with Emphasis on Cabbage: A Review.Biochemical genetics · 2023Review
- 6-Formyl Umbelliferone, a Furanocoumarin fromMolecules (Basel, Switzerland) · 2022Article
- The genusFrontiers in pharmacology · 2022Review
- Twice as Nice: The Duff Formylation of Umbelliferone Revised.Molecules (Basel, Switzerland) · 2021Article
- Umbelliferyloxymethyl phosphonate compounds-weakly binding zinc ionophores with neuroprotective properties.Dalton transactions (Cambridge, England : 2003) · 2021Article
- Insulin-Mimetic Dihydroxanthyletin-Type Coumarins fromAntioxidants (Basel, Switzerland) · 2021Article
- In Vitro Evaluation and Docking Studies of 5-oxo-5International journal of molecular sciences · 2019Article
- Angiotensin-I-Converting Enzyme Inhibitory Activity of Coumarins fromMolecules (Basel, Switzerland) · 2019Article
- Molecular Docking Studies of Coumarins Isolated from Extracts and Essential Oils ofMolecules (Basel, Switzerland) · 2019Article
- Anti-Neuroinflammatory Property of Phlorotannins fromMarine drugs · 2018Article
- Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease.Molecules (Basel, Switzerland) · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coumarins, which have low toxicity, are present in some natural foods, and are used in various herbal remedies, have attracted interest in recent years because of their potential medicinal properties. In this study, we report the isolation of two natural coumarins, namely umbelliferone (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.